SCHEMBL4692686

SCHEMBL4692686

CC(Nc1c(-c2ccc(F)cc2Cl)c(Cl)nc2c(C=O)cnn12)C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 1/20 0.31
JAK2 O60674 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4494475 0.91 KDM4E (0.31)
SCHEMBL4507666 0.86 GSK3B (0.36) SCN10A
SCHEMBL4489875 0.84 ADAM17 (0.32) SCN10A
SCHEMBL13606351 0.84 JAK2 (0.43) SCN10AJAK2
SCHEMBL4499049 0.84 SCN10A (0.33) SCN10AJAK2
SCHEMBL4690562 0.83 CDK2 (0.42)
SCHEMBL13606354 0.83 ALDH1A1 (0.37) SCN10AJAK2
SCHEMBL13606357 0.80 JAK2 (0.35) SCN10AJAK2
SCHEMBL5234861 0.80 JAK2 (0.31) JAK2
SCHEMBL13606388 0.80 CRHR1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694681-B1 PYRAZOLOPYRIMIDINES BAYER CROPSCIENCE AG (DE) 2008-03-12 EP disclosed
EP-1697372-B1 PYRAZOLOPYRIMIDINES BAYER CROPSCIENCE AG (DE) 2007-12-19 EP disclosed
EP-1697372-B1 PYRAZOLOPYRIMIDINES BAYER CROPSCIENCE AG (DE) 2007-12-19 EP disclosed
US-20070197540-A1 Pyrazolopyrimidines BAYER CROPSCIENCE AG (DE) 2007-08-23 US disclosed
US-20070197540-A1 Pyrazolopyrimidines BAYER CROPSCIENCE AG (DE) 2007-08-23 US disclosed
US-20070197540-A1 Pyrazolopyrimidines BAYER CROPSCIENCE AG (DE) 2007-08-23 US disclosed
US-20060276478-A1 Pyrazolopyrimidines BAYER CROPSCIENCE AG (DE) 2006-12-07 US disclosed
EP-1697372-A1 PYRAZOLOPYRIMIDINES Bayer CropScience AG (DE) 2006-09-06 EP disclosed
EP-1694681-A1 PYRAZOLOPYRIMIDINES Bayer CropScience AG (DE) 2006-08-30 EP disclosed
US-20060089499-A1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms UWW VENTURES UNLIMITED (GB) 2006-04-27 US disclosed
WO-2005056556-A1 PYRAZOLOPYRIMIDINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2005-06-23 WO disclosed
WO-2005056555-A1 PYRAZOLOPYRIMIDINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2005-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089499-A1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms PRDX1, PRDX2, PRDX5 SCN10A 4781/4885JAK2 2937/4885
US-20070197540-A1 Pyrazolopyrimidines QDPR, Q6ZSR9, RPLP2 SCN10A 4781/4885JAK2 877/4885
US-20060276478-A1 Pyrazolopyrimidines Q6ZSR9, RPLP2, DPYD SCN10A 4766/4885JAK2 1619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.